StockData
Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc. (RAPP) shareholders

RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$23.76−1.06 (-4.27%)

Close on Nov 17, 2026Market cap $1.14BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
51M of 48M shares
Institutional holders
161
29 new, 12 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
11 buys · 66 sales
Net sold $24.71M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Third Rock Ventures GP V, L.P.
Joint filing with Third Rock Ventures V, L.P. (19.50%), Trv Gp V, LLC (19.50%)
7,135,23319.50%13G (passive)Dec 31, 2024
Trv Gp V, LLC
Joint filing with Third Rock Ventures V, L.P. (13.10%), Third Rock Ventures GP V, L.P. (13.10%)
6,280,52513.10%13G (passive) amendmentJun 30, 2026
Abigail P. Johnson
Joint filing with FMR LLC (15.00%)
5,486,46815.00%13G (passive) amendmentNov 12, 2024
S) Kristina Burow
Joint filing with S) ARCH Venture Fund XII, L.P. (10.20%), S) ARCH Venture Partners XII, L.P. (10.20%) and 4 more
3,728,73810.20%13G (passive)Sep 30, 2024
Bihua Chen
Joint filing with Cormorant Asset Management, LP (6.19%)
2,957,5216.19%13G (passive) amendmentMar 31, 2026
Capital International Investors2,921,9586.10%13G (passive) amendmentJun 30, 2026
Cormorant Asset Management, LP
Joint filing with Bihua Chen (5.56%)
2,657,5215.56%13G (passive) amendmentJun 30, 2026
BlackRock, Inc.2,397,5495.03%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RAPPValueChange% of portfolio
FMR LLC7,172,89414.95%$298.89M+3,9550.01%
Trv Gp V, LLC6,280,52513.09%$261.71M−854,70852.53%
ARCH Venture Management, LLC3,728,7387.77%$155.38M–14.12%
Capital International Investors2,921,9586.09%$121.76M−176,0150.03%
Goldman Sachs Group Inc2,910,4496.07%$121.28M−31,8020.01%
BlackRock, Inc.2,699,7865.63%$112.50M+193,8310.00%
Cormorant Asset Management, LP2,657,5215.54%$110.74M−300,0005.67%
Sofinnova Investments, Inc.1,904,4083.97%$79.36M–4.10%
Johnson & Johnson1,784,5173.72%$74.36M–9.31%
Polar Capital Holdings Plc1,608,5143.35%$67.03M−33,9470.16%
Baker Bros. Advisors LP1,547,0903.22%$64.47M–0.32%
Vanguard Capital Management LLC1,346,5122.81%$56.11M+21,4300.00%
Trv Gp Vi, LLC969,2182.02%$40.39M–17.39%
State Street Corp818,7121.71%$34.12M+59,1600.00%
Geode Capital Management, LLC793,4531.65%$33.07M+71,8310.00%
Price T Rowe Associates Inc /Md/787,4461.64%$32.81M−79,0100.00%
Perceptive Advisors LLC773,3421.61%$32.23M+99,4190.48%
Vestal Point Capital, LP730,0001.52%$30.42M−706,2290.71%
Alliancebernstein L.P.693,3841.45%$21.70M−34,4590.01%
UBS Asset Management Americas Inc644,0821.34%$26.84M−274,7840.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202616151M100.0%29 / 5746 / 122M3M
Q1 202614752M100.0%30 / 5235 / 245M2M
Q4 202514451M100.0%40 / 5130 / 205M3M
Q3 202512449M100.0%51 / 3819 / 913M3M
Q2 20258238M80.2%15 / 2819 / 92M2M
Q1 20257738M79.4%17 / 359 / 92M1M
Q4 20247037M76.2%20 / 1815 / 59M1M
Q3 20245528M59.3%30 / 117 / 104M1M
Q2 20243526M53.3%35 / 00 / 026M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

174 funds held RAPP in Q2 2026, 26% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of RAPPValue% of fundAs of
SMALLCAP World Fund Inc3,113,1616.49%$129.73M0.14%Jun 30, 2026
Fidelity Growth Company Fund2,251,9684.69%$88.95M0.09%May 31, 2026
Vanguard Total Stock Market Index Fund986,7302.06%$41.12M0.00%Jun 30, 2026
iShares Russell 2000 ETF798,3251.66%$33.27M0.04%Jun 30, 2026
Fidelity Growth Company K6 Fund687,1151.43%$27.14M0.10%May 31, 2026
Fidelity Series Growth Company Fund592,1061.23%$23.39M0.10%May 31, 2026
T. Rowe Price Health Sciences Fund, Inc.571,9051.19%$23.83M0.20%Jun 30, 2026
Select Biotechnology Portfolio428,2730.89%$16.92M0.32%May 31, 2026
Fidelity Small Cap Index Fund335,4150.70%$13.75M0.04%Jul 31, 2026
Vanguard Extended Market Index Fund328,5980.68%$13.69M0.01%Jun 30, 2026
AB Small Cap Growth Portfolio301,4760.63%$12.56M0.40%Jun 30, 2026
SMALLCAP World Fund Inc278,5470.58%$11.61M0.01%Jun 30, 2026
iShares Russell 2000 Growth ETF264,2290.55%$11.01M0.07%Jun 30, 2026
T. Rowe Price Small-Cap Value Fund, Inc.229,7450.48%$9.57M0.09%Jun 30, 2026
iShares Biotechnology ETF200,6300.42%$8.36M0.09%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Abraham CeesayChief Executive Officer, Director552,4931.15%Oct 23, 2026
Troy A. IgnelziChief Financial Officer15,5000.03%Oct 21, 2026
Cheryl GaultChief Operating Officer139,9140.29%Oct 1, 2026
Krishnaswamy YeleswaramChief Development Officer212,0630.44%Aug 26, 2026
David BredtChief Scientific Officer393,0750.82%Feb 19, 2026
Jeffrey SevignyChief Medical Officer––Feb 4, 2026
Trv Gp V, LlcDirector, 10% owner––Nov 3, 2026
Third Rock Ventures VI, L.P.Director, 10% owner7,401,93315.43%Nov 3, 2026
Third Rock Ventures GP VI, L.P.Director, 10% owner––Nov 3, 2026
Trv Gp Vi, LlcDirector, 10% owner––Nov 3, 2026
Third Rock Ventures V, L.P.Director, 10% owner8,678,31418.09%Nov 3, 2026
Third Rock Ventures GP V, LPDirector, 10% owner––Nov 3, 2026
James HealyDirector2,873,8885.99%Oct 30, 2026
Ramiro SanchezDirector3,6000.01%Oct 23, 2026
Paul M. SilvaDirector3,6800.01%Oct 22, 2026
Steven M. PaulDirector555,0221.16%Oct 22, 2026
Wendy B. YoungDirector13,2890.03%Oct 22, 2026
John MaraganoreDirector9,4110.02%Oct 22, 2026
Reid M. HuberDirector20,4000.04%Jun 10, 2026
Robert J. PerezDirector––Jun 10, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Third Rock Ventures V, L.P.
Director, 10% owner
Oct 30, 2026Award+1,190,476$21.00$25.00M2,159,694
Third Rock Ventures V, L.P.
Director, 10% owner
Oct 30, 2026Award+238,095$21.00$5.00M6,518,620
James Healy
Director
Oct 28, 2026Buy+6,933$21.00$145.59K25,267
James Healy
Director
Oct 28, 2026Buy+3,772$21.00$79.21K14,924
James Healy
Director
Oct 28, 2026Buy+6,395$21.00$134.30K17,990
James Healy
Director
Oct 28, 2026Buy+952,380$21.00$20.00M2,815,707
Ramiro Sanchez
Director
Oct 23, 2026Buy+3,600$27.35$98.48K3,600
Paul M. Silva
Director
Oct 22, 2026Buy+3,680$27.07$99.64K3,680
Wendy B. Young
Director
Oct 22, 2026Buy+3,789$26.39$99.99K13,289
John Maraganore
Director
Oct 22, 2026Buy+1,172$26.92$31.55K9,411
John Maraganore
Director
Oct 22, 2026Buy+8,239$26.38$217.34K8,239
Steven M. Paul
Director
Oct 22, 2026Buy+35,714$27.28$974.28K77,380
Abraham Ceesay
Chief Executive Officer, Director
Oct 21, 2026Sale(10b5-1 plan)−2,210$29.16$64.45K450,035
Troy A. Ignelzi
Chief Financial Officer
Oct 21, 2026Buy+5,500$26.10$143.55K15,500
Abraham Ceesay
Chief Executive Officer, Director
Oct 7, 2026Sale(10b5-1 plan)−1,147$30.66$35.17K452,245
Abraham Ceesay
Chief Executive Officer, Director
Oct 6, 2026Sale(10b5-1 plan)−3,375$32.03$108.11K453,392
Cheryl Gault
Chief Operating Officer
Sep 30, 2026Sale(10b5-1 plan)−2,075$33.76$70.04K139,914
Cheryl Gault
Chief Operating Officer
Sep 30, 2026Sale(10b5-1 plan)−7,925$33.04$261.81K141,989
Abraham Ceesay
Chief Executive Officer, Director
Sep 23, 2026Sale(10b5-1 plan)−215$39.86$8.57K456,810
Abraham Ceesay
Chief Executive Officer, Director
Sep 23, 2026Sale(10b5-1 plan)−1,952$39.05$76.23K457,025
Abraham Ceesay
Chief Executive Officer, Director
Sep 23, 2026Sale(10b5-1 plan)−43$41.05$1.77K456,767
Abraham Ceesay
Chief Executive Officer, Director
Sep 8, 2026Sale(10b5-1 plan)−1,069$46.01$49.18K458,977
Abraham Ceesay
Chief Executive Officer, Director
Sep 8, 2026Sale(10b5-1 plan)−7,141$45.56$325.34K460,046
Abraham Ceesay
Chief Executive Officer, Director
Aug 25, 2026Sale(10b5-1 plan)−18,921$49.57$937.91K467,187
Krishnaswamy Yeleswaram
Chief Development Officer
Aug 25, 2026Sale(10b5-1 plan)−20,799$50.31$1.05M212,063
Krishnaswamy Yeleswaram
Chief Development Officer
Aug 25, 2026Sale(10b5-1 plan)−16,201$51.06$827.22K195,862
Krishnaswamy Yeleswaram
Chief Development Officer
Aug 24, 2026Sale(10b5-1 plan)−13,160$50.00$658.00K232,862
Krishnaswamy Yeleswaram
Chief Development Officer
Aug 19, 2026Sale(10b5-1 plan)−404$49.90$20.16K246,022
Abraham Ceesay
Chief Executive Officer, Director
Aug 11, 2026Sale(10b5-1 plan)−5,794$48.62$281.70K486,108
Abraham Ceesay
Chief Executive Officer, Director
Aug 11, 2026Sale(10b5-1 plan)−19,500$48.04$936.78K491,902
Abraham Ceesay
Chief Executive Officer, Director
Aug 11, 2026Sale(10b5-1 plan)−3,664$46.90$171.84K511,402
Abraham Ceesay
Chief Executive Officer, Director
Aug 10, 2026Sale(10b5-1 plan)−8,370$46.75$391.30K515,066
Abraham Ceesay
Chief Executive Officer, Director
Aug 10, 2026Sale(10b5-1 plan)−14,171$45.97$651.44K523,436
Abraham Ceesay
Chief Executive Officer, Director
Jul 27, 2026Sale(10b5-1 plan)−7$42.74$299537,607
Abraham Ceesay
Chief Executive Officer, Director
Jul 27, 2026Sale(10b5-1 plan)−2,203$42.11$92.77K537,614
Abraham Ceesay
Chief Executive Officer, Director
Jul 14, 2026Sale(10b5-1 plan)−5,481$39.72$217.71K542,546
Abraham Ceesay
Chief Executive Officer, Director
Jul 14, 2026Sale(10b5-1 plan)−2,729$40.57$110.72K539,817
Cheryl Gault
Chief Operating Officer
Jun 30, 2026Sale(10b5-1 plan)−3,792$41.39$156.95K154,222
Cheryl Gault
Chief Operating Officer
Jun 30, 2026Sale(10b5-1 plan)−1,900$40.09$76.17K158,014
Cheryl Gault
Chief Operating Officer
Jun 30, 2026Sale(10b5-1 plan)−3,308$42.17$139.50K150,914
Cheryl Gault
Chief Operating Officer
Jun 30, 2026Sale(10b5-1 plan)−1,000$43.15$43.15K149,914
Abraham Ceesay
Chief Executive Officer, Director
Jun 29, 2026Sale(10b5-1 plan)−7,344$39.77$292.07K548,903
Abraham Ceesay
Chief Executive Officer, Director
Jun 29, 2026Sale(10b5-1 plan)−876$40.34$35.34K548,027
Third Rock Ventures V, L.P.
10% owner
May 26, 2026Sale(10b5-1 plan)−18,572$40.05$743.81K6,280,525
Third Rock Ventures V, L.P.
10% owner
May 11, 2026Sale(10b5-1 plan)−133,618$40.24$5.38M6,299,097
Third Rock Ventures VI, L.P.
10% owner
May 8, 2026Sale(10b5-1 plan)−5,018$40.31$202.28K6,432,715
Third Rock Ventures VI, L.P.
10% owner
May 7, 2026Sale(10b5-1 plan)−271,495$40.12$10.89M6,437,733
Third Rock Ventures VI, L.P.
10% owner
Apr 17, 2026Sale(10b5-1 plan)−426,005$40.32$17.18M6,709,228
Krishnaswamy Yeleswaram
Chief Development Officer
Apr 17, 2026Sale(10b5-1 plan)−20,225$39.99$808.80K246,426
Krishnaswamy Yeleswaram
Chief Development Officer
Apr 14, 2026Sale(10b5-1 plan)−10,200$35.08$357.82K266,651
Krishnaswamy Yeleswaram
Chief Development Officer
Apr 13, 2026Sale(10b5-1 plan)−9,165$34.97$320.50K276,851
Krishnaswamy Yeleswaram
Chief Development Officer
Apr 10, 2026Sale(10b5-1 plan)−500$34.98$17.49K286,016
Krishnaswamy Yeleswaram
Chief Development Officer
Apr 8, 2026Sale(10b5-1 plan)−360$34.90$12.56K286,516
Cheryl Gault
Chief Operating Officer
Mar 30, 2026Sale(10b5-1 plan)−2,839$28.55$81.05K159,914
Cheryl Gault
Chief Operating Officer
Mar 30, 2026Sale(10b5-1 plan)−7,161$28.04$200.79K162,753
Krishnaswamy Yeleswaram
Chief Development Officer
Mar 25, 2026Sale(10b5-1 plan)−10,115$29.99$303.35K286,876
Cheryl Gault
Chief Operating Officer
Mar 5, 2026Sale−2,014$28.93$58.27K169,914
David Bredt
Chief Scientific Officer
Feb 19, 2026Option exercise+6,000$1.80$10.80K393,075
Abraham Ceesay
Chief Executive Officer, Director
Feb 18, 2026Sale(10b5-1 plan)−2,281$29.80$67.97K556,247
Abraham Ceesay
Chief Executive Officer, Director
Feb 18, 2026Sale(10b5-1 plan)−2,983$29.04$86.63K22,829

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
14.60%
4M shares short
Days to cover
1.8
At 2M shares a day
Change since last report
+29.7%
From 3M shares
Short volume, 20 days
56.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Rapport Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 894 shares on Sep 3, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Abraham Ceesay
Officer
Oct 6, 202639,470$1.23MOct 6, 2026Acquired as compensation -- Performance Awards
Cheryl Gault
Officer
Sep 30, 202610,000$330.20KSep 30, 2026Founders Shares
Krishnaswamy Yeleswaram
Officer
Aug 25, 202637,000$1.83MAug 25, 2026Founders Shares
Krishnaswamy Yeleswaram
Officer
Aug 24, 202611,472$553.41KAug 24, 2026Founders Shares
Krishnaswamy Yeleswaram
Officer
Aug 19, 20262,092$102.53KAug 19, 2026Founders Shares
Cheryl Gault
Officer
Jun 30, 202610,000$403.90KJun 30, 2026Founders Shares
Abraham Ceesay
Officer
Jun 29, 202699,480$4.02MJun 29, 2026Acquired as compensation -- Performance Awards
Third Rock Ventures V, L.P.
10% Stockholder
May 27, 202618,572$742.88KMay 26, 2026Original Issuance
Third Rock Ventures V, L.P.
10% Stockholder
May 11, 2026133,618$5.38MMay 11, 2026Original Issuance
Third Rock Ventures V, L.P.
10% Stockholder
May 8, 20265,018$202.25KMay 8, 2026Original Issuance
Third Rock Ventures V, L.P.
10% Stockholder
May 7, 2026271,495$10.89MMay 7, 2026Original Issuance
Krishnaswamy Yeleswaram
Officer
Apr 17, 202620,225$799.70KApr 17, 2026Founders Shares
Third Rock Ventures V, L.P.
10% Stockholder
Apr 17, 2026426,005$17.18MApr 17, 2026Original Issuance
Krishnaswamy Yeleswaram
Officer
Apr 13, 202619,365$661.70KApr 13, 2026Founders Shares
Krishnaswamy Yeleswaram
Officer
Apr 10, 2026500$17.11KApr 10, 2026Founders Shares

See a number that looks wrong?